Monitor for Q2 earnings filing (next 10-Q) to assess whether the CFO transition creates any reporting delays or internal control issues. The immediate internal appointment suggests continuity but concentration of finance oversight in the co-CEO may raise governance questions.
Price Chart
Executive Summary
Scienture Holdings CFO Eric Sherb resigned effective May 26, 2026 for personal reasons, with no dispute or disagreement. The company immediately appointed co-CEO and board member Dr. Narasimhan Mani as Interim CFO.
Key Facts
- Eric Sherb resigned as CFO effective May 26, 2026 for personal reasons, no dispute or disagreement with company
- Dr. Narasimhan Mani appointed Interim CFO same day; already serves as director, Co-CEO, and President since May 2025
- Dr. Mani has an MBA in Finance and Marketing from Columbia Business School and >25 years pharma experience including senior financial roles
Financial Impact
No financial figures provided in filing. CFO departure is an operational change with no disclosed financial impact.
Risk Factors
- CFO transition during a small-cap pharma company could indicate financial reporting or liquidity concerns not disclosed
- Interim CFO already serving as Co-CEO creates unusual concentration of financial authority
- No permanent CFO search timeline announced
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026414 |
| Document: 0001493152-26-026414-index-headers.html | 0001493152-26-026414 |
| Document: 0001493152-26-026414-index.html | 0001493152-26-026414 |
| Document: 0001493152-26-026414.txt | 0001493152-26-026414 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $2.77 | awaiting T+5 | — | $3.23 (+16.61%) |
Oct 19, 2026 8d ago | 8-K | $3.05 $3.23 | ▲ +5.90% | ▲ +5.82% | $3.23 (+5.90%) |
Oct 13, 2026 14d ago | Press Release | $3.24 $3.05 | ▲ +5.86% | ▲ +4.71% | $3.23 (+0.31%) |
Oct 7, 2026 20d ago | 8-K | $3.86 $3.38 | ▼ −12.44% | ▼ −12.16% | $3.23 (−16.32%) |
May 29, 2026 21w ago | 8-K | $0.3960 $0.3600 | ▼ −9.09% | ▼ −6.34% | $3.23 (+715.66%) |
May 22, 2026 22w ago | 8-K | $0.4000 $0.3910 | ▼ −2.25% | ▼ −3.46% | $3.23 (+707.50%) |
May 18, 2026 23w ago | Press Release | $0.3940 $0.4000 | ▲ +1.52% | ▼ −0.10% | $3.23 (+719.80%) |
May 5, 2026 25w ago | 8-K | $0.3910 $0.3980 | ▲ +1.79% | ▲ +0.66% | $3.23 (+726.09%) |
Apr 30, 2026 25w ago | 10-K/A | $0.4010 $0.4000 | ▲ +0.25% | ▲ +2.60% | $3.23 (−705.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers